STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to ...

Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...

Watch a subscriber-only discussion exploring longevity's new focus. Available only for MIT Alumni and subscribers. Listen to the session or watch below Billions of dollars are flooding into efforts to ...

Ancient genes from single-celled organisms have been used to reprogram mouse cells and influence embryonic development, revealing unexpected continuity across nearly a billion years of evolution.

Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Induced pluripotent stem cell (iPSC) technology has become a cornerstone of modern regenerative medicine, disease modeling, and cell‑based therapy development. Creative Biolabs stands out as a global ...

Induced pluripotent stem cells (iPSCs) are derived from adult cells, such as skin or blood cells, which have been “reprogrammed” back to a stem-cell-like state. This transformation grants them the ...

Induced pluripotent stem cells (iPSCs) are adult cells, such as skin or blood cells, that have been “reprogrammed” back into a stem-cell-like state. This reset gives them the remarkable ability to ...

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and manufacturing-ready reagent platforms are reshaping regenerative medicine and ...

iXCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent ...